<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00452179</url>
  </required_header>
  <id_info>
    <org_study_id>APD125-004</org_study_id>
    <nct_id>NCT00452179</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy Study of APD125 in Patient With Insomnia</brief_title>
  <official_title>A Randomized, Double-Blind, Placebo-Controlled, 3-Way Cross-Over Study to Evaluate the Effects of APD125 in Patients With Chronic Primary Insomnia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arena Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Arena Pharmaceuticals</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effects of APD125 in patients with sleep
      maintenance insomnia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2007</start_date>
  <completion_date type="Actual">June 2007</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Conventional PSG parameters</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient reported subjective sleep parameters</measure>
  </secondary_outcome>
  <enrollment type="Actual">173</enrollment>
  <condition>Insomnia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>APD125</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary insomnia as defined in DSM-IV-TR, with predominant complaint of impaired sleep
             maintenance and confirmed by PSG

          -  PSQI &gt;/= to 5

          -  Qualifying screening PSG parameters

          -  Generally good health

        Exclusion Criteria:

          -  History of any sleep disorder, other than primary insomnia (e.g., restless leg
             syndrome, narcolepsy, sleep apnea, and disorders of REM/NREM sleep)

          -  Any clinically significant medical condition, laboratory finding, or ECG finding

          -  Pregnant and/or lactating females

          -  History of substance abuse within 2 years or positive urine drug screen

          -  Positive Hepatitis B/C results or HIV markers

          -  Apnea-Hypopnea Index (AHI) or a Periodic Limb Movement Arousal Index (PLMAI) &gt; 10 as
             determined by screening PSG

          -  History of treatment with an investigational drug within the last month

          -  Recent travel involving crossing more than 3 time zones or plans to travel to another
             time zone (&gt; 3 time zones) during the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Warren A Prosser</last_name>
    <role>Study Director</role>
    <affiliation>Arena Pharmaceuticals</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.arenapharm.com</url>
    <description>Arena Pharmaceuticals Home Page</description>
  </link>
  <verification_date>September 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2007</study_first_submitted>
  <study_first_submitted_qc>March 26, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 27, 2007</study_first_posted>
  <last_update_submitted>September 6, 2007</last_update_submitted>
  <last_update_submitted_qc>September 6, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 10, 2007</last_update_posted>
  <keyword>Sleep maintenance</keyword>
  <keyword>Insomnia</keyword>
  <keyword>Sleep Consolidation</keyword>
  <keyword>Sleep</keyword>
  <keyword>Insomnia, primarily sleep maintenance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

